BR112014006429A2 - método e composição para tratamento de dor - Google Patents

método e composição para tratamento de dor

Info

Publication number
BR112014006429A2
BR112014006429A2 BR112014006429A BR112014006429A BR112014006429A2 BR 112014006429 A2 BR112014006429 A2 BR 112014006429A2 BR 112014006429 A BR112014006429 A BR 112014006429A BR 112014006429 A BR112014006429 A BR 112014006429A BR 112014006429 A2 BR112014006429 A2 BR 112014006429A2
Authority
BR
Brazil
Prior art keywords
composition
pain
pain treatment
analgesic
stored
Prior art date
Application number
BR112014006429A
Other languages
English (en)
Inventor
Rick Donald
K Chin Jennifer
Wallace Rosemarie
Original Assignee
Johnson & Johnson Consumer Companies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Companies Inc filed Critical Johnson & Johnson Consumer Companies Inc
Publication of BR112014006429A2 publication Critical patent/BR112014006429A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

abstract presented are methods of using topical analgesic compositions for rapid relief of muscular aches and pain where the analgesic composition has been stored at a temperature of less than 10o centigrade prior to use. ****************************** tradução do resumo resumo patente de invenção: "método e composição para tratamento de dor". são apresentados métodos para uso de composições analgésicas tópicas para o alívio rápido de dores musculares sendo que, antes do uso, a composição analgésica foi armazenada a uma temperatura menor que 10° celsius. jco5032usnp 1 20766651v1
BR112014006429A 2011-09-19 2012-09-19 método e composição para tratamento de dor BR112014006429A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/235,947 US20130072575A1 (en) 2011-09-19 2011-09-19 Method and Composition for Treating Pain
PCT/US2012/055979 WO2013043637A1 (en) 2011-09-19 2012-09-19 Method and composition for treating pain

Publications (1)

Publication Number Publication Date
BR112014006429A2 true BR112014006429A2 (pt) 2017-04-04

Family

ID=46940636

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006429A BR112014006429A2 (pt) 2011-09-19 2012-09-19 método e composição para tratamento de dor

Country Status (5)

Country Link
US (1) US20130072575A1 (pt)
EP (1) EP2758033A1 (pt)
BR (1) BR112014006429A2 (pt)
CA (1) CA2849078A1 (pt)
WO (1) WO2013043637A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2803354B1 (de) 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
CN105979953A (zh) * 2014-02-04 2016-09-28 阿什瓦尼·库马尔·邦萨 用于减轻疼痛、压力和失眠的组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404820A (en) * 1982-01-29 1983-09-20 Romaine John W Cold compress
US4590932A (en) * 1984-05-14 1986-05-27 Wilkerson Gary B Ankle-sprain edema-control boot assembly
US4671267A (en) * 1984-05-30 1987-06-09 Edward I. Stout Gel-based therapy member and method
GB8921710D0 (en) * 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
WO2000042848A1 (en) * 1999-01-19 2000-07-27 Bj Farmacéutica Ltda. Medicinal composition and its process of preparation
US6528076B2 (en) * 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
US20030032996A1 (en) * 2001-08-08 2003-02-13 Hallman Arlan Jay Cryogenic massage tube and compress
US20030059446A1 (en) * 2001-09-18 2003-03-27 Kulkarni Arun B. Physically stable sprayable gel composition
US20090257968A1 (en) * 2004-03-25 2009-10-15 Richard Walton Gels containing anionic surfactants and coupling agents
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US20060064148A1 (en) * 2004-09-23 2006-03-23 Sammarco Domenic A Self-adherent instant cold compress therapeutic wrap
CH699814B1 (de) * 2007-05-14 2010-05-14 Mepha Ag Diclofenac zur topischen Anwendung als Spray.

Also Published As

Publication number Publication date
WO2013043637A1 (en) 2013-03-28
CA2849078A1 (en) 2013-03-28
US20130072575A1 (en) 2013-03-21
EP2758033A1 (en) 2014-07-30

Similar Documents

Publication Publication Date Title
PH12016500105A1 (en) Sulfonamides as modulators of sodium channels
MX359882B (es) Amidas como moduladores de canales de sodio.
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
PH12015501661A1 (en) Pyridone amides as modulators of sodium channels
BR112012023021A2 (pt) compostos de indazol e seus usos
IN2014MN01755A (pt)
MX368833B (es) Derivados de quinolina y quinazolina amidas como inhibidores de canales de sodio nav1.8 y el uso de los mismos en el tratamiento del dolor.
PE20180399A1 (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
WO2015157559A3 (en) 10',11'-modified saxitoxins useful for the treatment of pain
MX2012007933A (es) Composiciones de dexmedetomidina transdermicas topicas y metodos para su uso.
CU20120171A7 (es) Triazolopiridinas sustituidas
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
DOP2015000170A (es) Compuestos químicos
MY157429A (en) Trpm8 antagonists and their use in treatments
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
MX354697B (es) Composiciones de gel de brimonidina y métodos de uso.
CL2014002845A1 (es) Compuestos derivados de pirazol inhibidores de sglt1; metodo para tratar la diabetes; composicion farmaceutica; uso del compuesto para el tratamiento de la diabetes tipo 1 y tipo 2.
MX2015008187A (es) Inhibidores de alk deuterados.
UA112418C2 (uk) Терапевтичний болезаспокійливий засіб
BR112014006429A2 (pt) método e composição para tratamento de dor
CU20130004A7 (es) Agentes terapéuticos 976
CL2016002655A1 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
CO7170180A2 (es) Composición farmacéutica inyectable de dexketoprofeno y tramadol
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2532 DE 16-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.